News Conference News ACC 2025 WARRIOR: No Clear Answers on How to Best Treat INOCA Yael L. Maxwell March 29, 2025
News Daily News Deferred Testing in Low-Risk Patients Safe, May Curb Symptoms: PRECISE Yael L. Maxwell August 23, 2023
News Daily News REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects Shelley Wood April 12, 2023
News Conference News ACC 2023 On-site Machine Learning-Based FFRCT Feasible, Informative: TARGET Caitlin E. Cox March 04, 2023
Presentation AHA 2022 Comparison of a Precision Care Strategy With Usual Testing To Guide Management Of Stable Patients With Suspected Coronary Artery Disease Presenter: Pamela S. Douglas November 07, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Conference News TCT 2021 Debating ISCHEMIA: Do the Results Apply to CABG, Too? Michael O'Riordan November 10, 2021
News Conference News AHA 2020 SCAPIS: CTA Finds Silent CAD in 42% of Middle-aged Adults Shelley Wood November 13, 2020
News Conference News AHA 2019 ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events Shelley Wood November 16, 2019
News Daily News CT Angiography Bests Functional Testing in Diabetic Patients With Chest Pain: PROMISE Michael O'Riordan February 25, 2019
News Conference News ESC 2018 FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry Caitlin E. Cox September 07, 2018
News Daily News The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money Yael L. Maxwell June 14, 2018
News Daily News PET More Accurate for Diagnosing CAD Than SPECT and CT Angiography: PACIFIC Study Michael O'Riordan August 17, 2017
News Conference News ACC 2017 My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time Shelley Wood March 23, 2017
News Opinion Editor's Corner TCT 2016 TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever Shelley Wood October 24, 2016
News Daily News PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year Michael O'Riordan July 27, 2016
News Daily News PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año Michael O'Riordan July 27, 2016
News Conference News AHA 2014 FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes November 16, 2014